However, population-specific frequency differences exist on top: In the present study, the frequency of HLA-DRB1*15:01 was markedly higher in Swedish (36.1%) than in German MS patients (30.9%). This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.